From Bedside to Bench: A New Direction in Breast Cancer Research
Past AACR president Dr Carlos Arteaga describes translational studies and emerging therapies that are transforming the clinical practice of breast cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - January 12, 2016 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Myeloma Takeaways From ASH 2015: New Drugs, Regimens
Dr Saad Usmani highlights the key takeaways on newly diagnosed and relapsed/refractory myeloma from the 57th American Society of Hematology Annual Meeting. (Source: Medscape Oncology)
Source: Medscape Oncology - December 23, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
CML Takeaways From ASH 2015: Discontinuing TKIs
Live from the ASH meeting floor, Dr Jerald Radich discussed his thoughts on therapy discontinuation for CML patients. (Source: Medscape Oncology)
Source: Medscape Oncology - December 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Acute Leukemia Takeaways From ASH 2015: New Agents
Dr Farhad Ravandi provides an overview of the highlights in acute myeloid leukemia and acute lymphoblastic leukemia from the 2015 American Society of Hematology Annual Meeting. (Source: Medscape Oncology)
Source: Medscape Oncology - December 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Cut Clinical Trial Costs the Smart Way
Dr Daniel Sargent reports that 40% of the costs of clinical trials go to monitoring data, much of which are irrelevant. By revamping monitoring practices, trial costs can be cut substantially. (Source: Medscape Oncology)
Source: Medscape Oncology - December 18, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
No Such Thing as Work-Life Balance
Three young oncologists from different specialties and practice settings see the elusive work/life balance as less important as work/life choices when aiming for a gratifying life and career. (Source: Medscape Oncology)
Source: Medscape Oncology - December 14, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Stakeholders to Scope Out Value in GI Cancer Therapy
Dr John Marshall previews the upcoming 2015 Ruesch Symposium, in which policy makers, insurers, regulators, researchers, and patients debate about what therapies are worth pursuing in GI cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - November 30, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Being 30-Something in Oncology
Dr Sheetal Kircher says 30-something oncologists need to reset priorities, when after years of independent decisions, career choices must take into account spouse, family, and life outside of work. (Source: Medscape Oncology)
Source: Medscape Oncology - November 13, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Patient Advocates Emerge as Key Stakeholders
Patient advocates have emerged as sophisticated stakeholders who understand the healthcare system and are knowledgeable about pertinent scientific developments in their disease area. (Source: Medscape Oncology)
Source: Medscape Oncology - October 21, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Value in Cancer Care: But at What Price?
Experts take on the issue of value in cancer care -- among the hottest topics of ASCO 2015 -- and what is at stake if efforts to ensure value do not succeed in containing healthcare costs. (Source: Medscape Oncology)
Source: Medscape Oncology - July 13, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
The Frightening Truth About Genetic Testing
Genetic testing is now ordered in the treatment of numerous cancer types. Is it useful? Is it even reliable? Dr John Marshall and world-class experts tackle key questions for practicing clinicians. (Source: Medscape Oncology)
Source: Medscape Oncology - June 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Not Working Out: Getting Cancer Patients to Just Do It
Mounting evidence suggests diet and exercise help prevent cancer recurrence, but what changes should patients focus on? And what can and should doctors do to help cancer patients change their ways? (Source: Medscape Oncology)
Source: Medscape Oncology - June 15, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Money Talks: Solution to Soaring Costs of Cancer Drugs?
A panel of oncologists and patient advocates takes on the challenge of what to do about rising cancer care costs--and hits upon a solution both simple and challenging: talk to patients about money. (Source: Medscape Oncology)
Source: Medscape Oncology - June 15, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Perirectal Spacing in Prostate Radiation: Worth the Cost?
Protecting the rectum from radiation while treating prostate cancer may have some benefit, but the relative costs need to be considered, says Dr Gerald Chodak. (Source: Medscape Oncology)
Source: Medscape Oncology - June 10, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
Over-the-Counter Tx Proves Top Shelf in CRC
Dr David Kerr's top picks for the colorectal cancer presentations at ASCO 2015 surprisingly include two studies on vitamin D supplements and aspirin for patients diagnosed with colorectal cancer. (Source: Medscape Oncology)
Source: Medscape Oncology - May 22, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts
